[144] Lifeway Foods, Inc. SEC Filing

Rhea-AI Filing Summary

Lifeway Foods insider intends to sell 26,847 common shares (approximately $697,586.60 in aggregate market value) through Merrill Lynch on NASDAQ around 10/01/2025. The filing shows all 26,847 shares were acquired as compensation from the issuer on multiple dates between 07/28/2005 and 07/01/2025. The total number of outstanding shares is listed as 15,226,520, and the transaction will be executed via broker-dealer Merrill Lynch at 75 Rockefeller Plaza, New York.

Insights

Securities Analyst

TL;DR: Insider plans to sell 26,847 shares acquired as compensation across several years; sale routed through Merrill Lynch on NASDAQ.

This Form 144 discloses a proposed Rule 144 sale of 26,847 common shares with an aggregate market value of $697,586.60, representing a small fraction of the 15,226,520 shares outstanding. All shares were recorded as compensation from the issuer on discrete dates from 2005 through 2025, indicating transfers from vested awards or similar compensation mechanisms rather than open-market purchases. The planned execution through a major broker-dealer is consistent with standard Rule 144 compliance and orderly disposition.

Corporate Governance Specialist

TL;DR: Disclosure aligns with Rule 144 requirements; cumulative sale equals sum of previously reported compensation grants.

The filing transparently aggregates multiple compensation-originated share lots totaling 26,847 shares, matching the scheduled quantity for sale. The notice includes the broker, approximate sale date, and outstanding share count, providing investors with clear visibility on an insider disposition. There is no reporting here of other recent sales in the past three months, and no additional explanatory remarks about motive or trading plans are provided in the document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 75 Rockefeller Plz Flr 2 New York NY 10019	26847	697586.6	15226520	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2024	Compensation	Issuer			1758	08/12/2024	Compensation
Common	09/03/2024	Compensation	Issuer			3151	09/03/2024	Compensation
Common	07/01/2025	Compensation	Issuer			1356	07/01/2025	Compensation
Common	08/31/2023	Compensation	Issuer			1600	08/31/2023	Compensation
Common	08/12/2023	Compensation	Issuer			1757	08/12/2023	Compensation
Common	07/14/2023	Compensation	Issuer			3111	07/14/2023	Compensation
Common	07/15/2020	Compensation	Issuer			10312	07/15/2020	Compensation
Common	07/28/2005	Compensation	Issuer			3802	07/28/2005	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by Lifeway Foods (LWAY) disclose?

The form discloses a proposed sale of 26,847 common shares with an aggregate market value of $697,586.60, to be sold via Merrill Lynch on NASDAQ around 10/01/2025.

How were the 26,847 shares acquired according to the filing?

All 26,847 shares were recorded as compensation from the issuer, acquired on specific dates between 07/28/2005 and 07/01/2025.

What fraction of Lifeway Foods' outstanding shares does this proposed sale represent?

The filing lists 15,226,520 shares outstanding. The proposed sale of 26,847 shares represents a small fraction of that total (26,847 of 15,226,520).

Which broker will handle the sale listed in the Form 144?

The broker named in the filing is Merrill Lynch, 75 Rockefeller Plaza, New York, NY.

Does the filing report any sales by the same person in the past three months?

The filing indicates "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.